These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liver organ allocation for hepatocellular carcinoma: are we sure? Marsh JW; Dvorchik I Liver Transpl; 2003 Jul; 9(7):693-6. PubMed ID: 12827554 [TBL] [Abstract][Full Text] [Related]
4. The ethics of competition in liver transplantation. Thomasma DC; Micetich KC; Brems J; Van Thiel D Camb Q Healthc Ethics; 1999; 8(3):321-9. PubMed ID: 10388932 [No Abstract] [Full Text] [Related]
5. Access to liver transplantation: can we do a better job? Cacciarelli TV Liver Transpl; 2005 Nov; 11(11):1318-9. PubMed ID: 16237694 [No Abstract] [Full Text] [Related]
6. Survival of the sickest. Organ allocation should be based on patients' medical need, not location. Fung J Mod Healthc; 1998 Aug; 28(33):29. PubMed ID: 10183081 [No Abstract] [Full Text] [Related]
7. Recasting the debate on multiple listing for transplantation through consideration of both principles and practice. Ankeny RA Camb Q Healthc Ethics; 1999; 8(3):330-9. PubMed ID: 10388933 [No Abstract] [Full Text] [Related]
8. The Mick and the liver: is organ allocation fair? La Puma J Manag Care; 1995 Aug; 4(8):49-50. PubMed ID: 10145015 [No Abstract] [Full Text] [Related]
9. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Sponseller CA; Bacon BR; Di Bisceglie AM Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057 [TBL] [Abstract][Full Text] [Related]
10. Assessing patient compliance in the selection of organ transplant recipients. Kinkopf-Zajac I Health Matrix Clevel; 1996; 6(2):503-51. PubMed ID: 10178395 [No Abstract] [Full Text] [Related]
11. Worth its weight in gold: organ transplantation and the new UNOS policies for allocation of hearts and livers. Heitz TL; Kayira EF J Health Hosp Law; 1997; 30(3):195-200. PubMed ID: 10179115 [No Abstract] [Full Text] [Related]
12. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Berenguer M; Prieto M; Rayón JM; Mora J; Pastor M; Ortiz V; Carrasco D; San Juan F; Burgueño MD; Mir J; Berenguer J Hepatology; 2000 Oct; 32(4 Pt 1):852-8. PubMed ID: 11003634 [TBL] [Abstract][Full Text] [Related]
13. MELD and PELD: application of survival models to liver allocation. Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR Liver Transpl; 2001 Jul; 7(7):567-80. PubMed ID: 11460223 [No Abstract] [Full Text] [Related]
14. Utility of liver allograft biopsy obtained at procurement. Lo IJ; Lefkowitch JH; Feirt N; Alkofer B; Kin C; Samstein B; Guarrera JV; Renz JF Liver Transpl; 2008 May; 14(5):639-46. PubMed ID: 18324657 [TBL] [Abstract][Full Text] [Related]
15. Extended criteria donors: the case for liver procurement in donors with a central nervous system malignancy. Detry O Liver Transpl; 2009 Jun; 15(6):670-1. PubMed ID: 19479814 [No Abstract] [Full Text] [Related]
16. A critique of UNOS liver allocation policy. United Network for Organ Sharing. Himma KE Camb Q Healthc Ethics; 1999; 8(3):311-20. PubMed ID: 10388931 [No Abstract] [Full Text] [Related]